Is copper chelation an effective anti-angiogenic strategy for cancer treatment?

Medical Hypotheses

Volumn 81, Issue 6, 2013, Pages 1159-1163

  Antoniades, V ^a   Sioga, A ^a   Dietrich, E M ^a   Meditskou, S ^a   Ekonomou, L ^a   Antoniades, K ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; GELATINASE B; GROWTH FACTOR; PENICILLAMINE; THROMBOSPONDIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CELL; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHELATION; CHELATION THERAPY; COPPER CHELATION; COPPER METABOLISM; DEGRADATION KINETICS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HYPOTHESIS; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; OXIDATIVE STRESS;

ANIMALIA; MUS; ORYCTOLAGUS CUNICULUS;

ANGIOGENESIS INHIBITORS; ANIMALS; CHELATION THERAPY; COPPER; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; RABBITS;

EID: 84888431221     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.09.035     Document Type: Article

References (54)

1. Folkman J. Tumor angiogenesis. The molecular basis of cancer 1995, 206-232. W.B. Saunders, Philadelphia. J. Mendelsohn, P.M. Howley, M.A. Israel, L.A. Liotta (Eds.).
2. Folkman J., Hannahan D. Switch to the angiogenic phenotype during tumorigenesis. Princess Takamatsu Symp 1991, 22:339-347.
3. Lingen M.W., Dipietro L.P., Solt D.B., Bouck N.P., Polverini P.J. The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TFGb-1 and is unaffected by ras activation. Carcinogenesis 1997, 18:329-338.
4. Khan G.N., Merajver S.D. Modulation of angiogenesis for cancer prevention: strategies based on antioxidants and copper deficiency. Curr Pharm Des 2007, 13:3584-3590.
5. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
6. Boehm T., Folkman J., Browder T., O'Reilly M.S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997, 390:404-407.
7. Schumacker P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006, 10:175-176.
8. Goodman V.L., Brewer G.J., Merajver S.D. Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer 2004, 11:255-263.
9. Gupte A., Mumper R.J. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 2009, 35:32-46.
10. Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Ann Rev Nutr 2002, 22:439-458.
11. Crichton R.R., Pierre J.L. Old iron, young copper: from Mars to Venus. Biometals 2001, 14:99-112.
12. Harris Z.L., Gitlin J.D. Genetic and molecular basis for copper toxicity. Am J Clin Nutr 1996, 63:836-841.
13. Silver S. BioMetals: a historical and personal perspective. BioMetals 2011, 24:379-390.
14. Brewer G.J. Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug Discov Today 2005, 10:1103-1109.
15. Trivedy C., Meghji S., Warnakulasuriya K.A., Johnson N.W., Harris M. Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. Oral Pathol Med 2001, 30:465-470.
16. Khanna S. Immunological and biochemical markers in oral carcinogenesis: the public health perspective. Int J Environ Res Public Health 2008, 5:418-422.
17. Gullino P.M., Ziche M., Alessandri G. Gangloosides, copper ions and angiogenic capacity of adult tissues. Cancer Metastaasis Rev 1990, 9:239-251.
18. Brem S.S., Zagzag D., Tsanaclis A.M., Gately S., Elkouby M.P., Brien S.E. Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol 1990, 137:1121-1142.
19. Brem S., Grossman S.A., Carson K.A., et al. New approaches to brain tumor therapy CNS consortium. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol 2005, 7:246-253.
20. Kuo K.W., Chen S.F., Wu C.C., Chen D.R., Lee J.H. Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res 2002, 89:1-11.
21. Floyd R.A. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 1990, 4:2587-2597.
22. Floyd R.A., Schneider J.E. Hydroxy free radical damage to DNA. Membrane lipid oxidation 1990, C.R.C. Press, Boca Raton, Florida. C. Vigo-Pelfrey (Ed.).
23. Rainis T., Maor I., Lanir A., Shnizer S., Lavy A. Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig Dis Sci 2007, 52:526-530.
24. Pan Q., Kleer C.G., van Golen K.L., et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res 2002, 62:4854-4859.
25. Cox C., Teknos T.N., Barrios M., Brewer G.J., Dick R.D., Merajver S.D. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 2001, 111:696-701.
26. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995, 18:775-794.
27. Pervaiz S., Clement M.V. Tumor intracellular redox status and drug resistance - serendipity or a causal relationship?. Curr Pharm Des 2004, 10:1969-1977.
28. Daniel K.G., Gupta P., Harbach R.H., Guida W.C., Dou Q.P. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells. Biochem Pharmacol 2004, 67:1139-1151.
29. Tisato F., Marzano C., Porchia M., Pellei M., Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 2010, 30:708-749.
30. Lowndes S.A., Harris A.L. The role of copper in tumour angiogenesis. J Mammary Gland Biol Neoplasia 2005, 10:299-310.
31. McAuslan B.R., Reilly W. Endothelial cell phagokinesis in response to specific metal ions. Exp Cell Res 1980, 130:147-157.
32. McAuslan B.R., Hannan G.N., Reilly W., Stewart F.H. Variant endothelial cells. Fibronectin as a transducer of signals for migration and neovascularisation. J Cell Physiol 1980, 104(2):177-186.
33. Gullino P.M. Considerations on the mechanisms of the angiogenic response. Anticancer Res 1986, 6:153-158.
34. Hu G.F. Copper stimulates proliferation of human endothelial cells under culture. Cell Biochem 1998, 69:326-335.
35. Finney L., Vogt S., Fukai T., Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol 2009, 36:88-94.
36. McAuslan B.R. A new theory of neovascularization based on identification of an angiogenic factor and its effect on cultured endothelial cells. Control mechanisms in animal cells 1980, 285-292. Raven Press, New York. S. Iacobelli, L. Jiminez de Asua, R. Shields, R. Levi Montalcini (Eds.).
37. Barnes D. Growth factors involved in repair processes: an overview. Methods Enzymol 1988, 163:707-715.
38. Badet J., Soncin F., Guitton J.D., Lamare O., Cartwright T., Barritault D. Specific binding of angiogenin to calf pulmonary artery endothelial cells. Proc Natl Acad Sci U S A 1989, 86:8427-8431.
39. Pan Q., Bao L.W., Merajver S.D. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res 2003, 1:701-706.
40. Huang S., Pettaway C.A., Uehara H., Bucana C.D., Fidler I.J. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001, 20:4188-4197.
41. Kim J., Yu W., Kovalski K., Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 1998, 94:353-362.
42. Choi B.Y., Jang B.G., Kim J.H., et al. Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model. Neurobiol Dis 2013, 54:382-391.
43. Bergers G., Brekken R., McMahon G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744.
44. Hiratsuka S., Nakamura K., Iwai S., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2:289-300.
45. Nozawa H., Chiu C., Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A 2006, 103:12493-12498.
46. Bausch D., Pausch T., Krauss T., et al. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 2011, 14:235-243.
47. Erler J.T., Bennewith K.L., Cox T.R., et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 2009, 15:35-44.
48. Jain S., Cohen J., Ward M.M., et al. Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse. Ann Oncol 2013, 24:1491-1498.
49. Elsherif L., Jiang Y., Saari J.T., Kang Y.J. Dietary copper restriction-induced changes in myocardial gene expression and the effect of copper repletion. Exp Biol Med (Maywood) 2004, 229:616-622.
50. Rodríguez-Manzaneque, Lane T.F., María A.O., Hynes R.O., Lawler J.M., Iruela-Arispe L. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 2001, 98:12485-12490.
51. Stokes A., Joutsa J., Ala-Aho R., et al. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res 2010, 16:2022-2035.
52. Luukkaa H., Klemi P., Leivo I., et al. Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer. Head Neck 2010, 32:1019-1027.
53. Vilen S.T., Salo T., Sorsa T., Nyberg P. Fluctuating roles of matrix metalloproteinase-9 in oral squamous cell carcinoma. Scientif World J 2013, 2013:920595.
54. Auerbach R., Alby L., Morrissey L.W., Tu M., Joseph J. Expression of organ-specific antigens on capillary endothelial cells. Microvasc Res 1985, 29:401-411.